CVAC Competitors & Alternatives
Compare CureVac NV with similar stocks in the same industry
Biotechnology
CVAC
Main Stock$4.66
Tradestie Score
54
Market Cap
$1.22B
P/E Ratio
7.0
Revenue Growth
-0.9%
Analyst Upside
+15.6%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$36.42
|
$1.13B | - | 33 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$3.24
|
$1.12B | - | 37 | Compare |
|
NKTR
Nektar Therapeutics
|
$37.79
|
$1.12B | - | 57 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$330.73
|
$1.12B | - | 32 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$6.37
|
$1.09B | - | 46 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$13.18
|
$1.05B | 41.3 | 21 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.98
|
$996.55M | - | 43 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$103.84
|
$994.20M | - | 44 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.84
|
$993.46M | - | 50 | Compare |
|
IMNM
Immunome, Inc.
|
$18.54
|
$987.09M | - | 46 | Compare |
More CVAC Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry